These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


313 related items for PubMed ID: 3543054

  • 1. Hyperglucagonemia and insulin-mediated glucose metabolism.
    Del Prato S, Castellino P, Simonson DC, DeFronzo RA.
    J Clin Invest; 1987 Feb; 79(2):547-56. PubMed ID: 3543054
    [Abstract] [Full Text] [Related]

  • 2. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA.
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [Abstract] [Full Text] [Related]

  • 3. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
    Petrides AS, Groop LC, Riely CA, DeFronzo RA.
    J Clin Invest; 1991 Aug; 88(2):561-70. PubMed ID: 1864966
    [Abstract] [Full Text] [Related]

  • 4. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
    Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA.
    J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
    [Abstract] [Full Text] [Related]

  • 5. Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
    Lillioja S, Bogardus C, Mott DM, Kennedy AL, Knowler WC, Howard BV.
    J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702
    [Abstract] [Full Text] [Related]

  • 6. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A, Defronzo RA, Thorin D, Jequier E, Felber JP.
    Diabete Metab; 1988 Apr; 14(4):443-51. PubMed ID: 3066652
    [Abstract] [Full Text] [Related]

  • 7. Role of glucagon in disposal of an amino acid load.
    Boden G, Tappy L, Jadali F, Hoeldtke RD, Rezvani I, Owen OE.
    Am J Physiol; 1990 Aug; 259(2 Pt 1):E225-32. PubMed ID: 1974387
    [Abstract] [Full Text] [Related]

  • 8. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [Abstract] [Full Text] [Related]

  • 9. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.
    Ebeling P, Koivisto VA.
    Diabetologia; 1994 Feb; 37(2):202-9. PubMed ID: 8163056
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.
    Golay A, DeFronzo RA, Ferrannini E, Simonson DC, Thorin D, Acheson K, Thiébaud D, Curchod B, Jéquier E, Felber JP.
    Diabetologia; 1988 Aug; 31(8):585-91. PubMed ID: 3065112
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R, Verdonk C, Miles J, Service FJ, Gerich J.
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [Abstract] [Full Text] [Related]

  • 15. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J, Efendić S, Luft R, Hagenfeldt L, Björkman O, Felig P.
    J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
    [Abstract] [Full Text] [Related]

  • 16. Regulation of free fatty acid metabolism by glucagon.
    Carlson MG, Snead WL, Campbell PJ.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):11-5. PubMed ID: 8100827
    [Abstract] [Full Text] [Related]

  • 17. Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue.
    Solini A, Bonora E, Bonadonna R, Castellino P, DeFronzo RA.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2552-8. PubMed ID: 9253333
    [Abstract] [Full Text] [Related]

  • 18. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 19. Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.
    Beylot M, Khalfallah Y, Riou JP, Cohen R, Normand S, Mornex R.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):9-15. PubMed ID: 3519651
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
    Singh V, Grötzinger C, Nowak KW, Zacharias S, Göncz E, Pless G, Sauer IM, Eichhorn I, Pfeiffer-Guglielmi B, Hamprecht B, Wiedenmann B, Plöckinger U, Strowski MZ.
    Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.